Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Dhanunjaya Lakkireddy MD, FACC, FHRS

Dhanunjaya Lakkireddy MD, FACC, FHRS

Medical Director, Kansas City Heart and Rhythm Institute, HCA Midwest Health, Kansas City, Kansas

Dr. Lakkireddy is the Executive Medical Director of the Kansas City Heart Rhythm Institute at HCA Midwest in Overland Park, Kansas and an adjunct Professor of Medicine at the University of Missouri-Columbia. He is a highly-published author with > 350 peer-reviewed papers and abstracts in various national and international meetings and journals. His clinical practice is focused on a wide variety of arrhythmia management and their ablation and pacemaker and ICD/CRT-D therapies. He has done extensive research on oral anticoagulation and systemic thromboembilization, publishing seminal papers on uninterrupted oral anticoagulation during procedures; the connection between myocarditis and premature ventricular contractions and non-ischemic cardiomyopathy; and is internationally known for his expertise in left atrial appendage closure devices.


Disclosures: Medtronic, Abbott, Boston Scientific, Atricure, AltaThera Pharmacueticals, Biosense Webster, LifeTech, Phillips, Biotronik, Sanofi